Novan (NOVNW) Gross Profit : $16.26 Mil (TTM As of Mar. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Novan Gross Profit?

Novan's gross profit for the three months ended in Mar. 2023 was $1.71 Mil. Novan's gross profit for the trailing twelve months (TTM) ended in Mar. 2023 was $16.26 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Novan's gross profit for the three months ended in Mar. 2023 was $1.71 Mil. Novan's Revenue for the three months ended in Mar. 2023 was $3.00 Mil. Therefore, Novan's Gross Margin % for the quarter that ended in Mar. 2023 was 57.11%.

Novan had a gross margin of 57.11% for the quarter that ended in Mar. 2023 => Durable competitive advantage

During the past 9 years, the highest Gross Margin % of Novan was 68.74%. The lowest was 65.78%. And the median was 68.74%.

Novan Gross Profit Historical Data

The historical data trend for Novan's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novan Gross Profit Chart

Novan Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Gross Profit

Get a 7-Day Free Trial

5.99

4.48

4.21

2.82

16.23

Novan Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Gross Profit	Get a 7-Day Free Trial															1.69	3.54	3.66	7.35	1.71

Competitive Comparison of Novan's Gross Profit

For the Biotechnology subindustry, Novan's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novan's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novan's Gross Profit distribution charts can be found below:

* The bar in red indicates where Novan's Gross Profit falls into.

Novan Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Novan's Gross Profit for the fiscal year that ended in Dec. 2022 is calculated as

Gross Profit (A: Dec. 2022 )	=	Revenue	-	Cost of Goods Sold
	=	23.609	-	7.379
	=	16.23

Novan's Gross Profit for the quarter that ended in Mar. 2023 is calculated as

Gross Profit (Q: Mar. 2023 )	=	Revenue	-	Cost of Goods Sold
	=	2.996	-	1.285
	=	1.71

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $16.26 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Novan's Gross Margin % for the quarter that ended in Mar. 2023 is calculated as

Gross Margin % (Q: Mar. 2023 )	=	Gross Profit (Q: Mar. 2023 )	/	Revenue (Q: Mar. 2023 )
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	1.71	/	2.996
	=	57.11 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Novan (OTCPK:NOVNW) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Novan had a gross margin of 57.11% for the quarter that ended in Mar. 2023 => Durable competitive advantage

Novan Gross Profit Related Terms

Thank you for viewing the detailed overview of Novan's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.

Novan Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novan Inc (OTCPK:NOVNW) » Definitions » Gross Profit

Comparable Companies

Traded in Other Exchanges

N/A

Address

P.O. Box 64, Pittsboro, NC, USA, 27312

Website

https://www.novan.com

NVN Liquidation Inc Formerly Novan Inc is a dermatology company focused on developing and commercializing therapeutic products for skin diseases. It is developing SB206 as a topical prescription gel for the treatment of viral skin infections. The company's product portfolio includes; Wynzora Cream for the treatment of plaque psoriasis, Rhofade cream for the treatment of persistent facial erythema, Minolira tablets to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients, Cloderm cream for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, Sitavig tablets for the treatment of recurrent herpes labialis in immunocompetent adults, and Nuvail nail solution for managing signs and symptoms of nail dystrophy.